ELRO PHARMA SARL
2Patents
2Active
2Granted
41Portfolio score
Filing activity: May 22, 2008 → Oct 4, 2011 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9243030B2 | Optically pure compounds for improved therapeutic efficiency | Human Necessities | 0 | Active |
| US9487559B2 | Compositions comprising multivalent synthetic ligands of surface nucleolin and glycosaminoglycans | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.